Bruce Dembofsky holds a Master of Science degree in Chemistry from The University of Connecticut. He has a passion for innovation, lab process optimization, and all types of science.
Bruce started his career at Cephalon, Inc. in 1992 and in 1995 Bruce moved to AstraZeneca Pharmaceuticals where he held a variety of R&D roles. His scientific research has focused on small molecule drugs for Neuroscience indications including work in Alzheimer’s, Anxiety, Depression, and Schizophrenia. Bruce has contributed to more than fifteen peer reviewed scientific publications and is an inventor on multiple patents for novel molecules and their therapeutic applications.
Since joining Avantor in 2010 Bruce has held positions in the Laboratory Services division. He is currently Director of Scientific Services with responsibility for Lab Services innovation and technical Lab Services program development. He is recognized in Avantor globally as an innovation leader and is passionate about creating world-class customer experiences for Avantor’s science focused customers.